Fentanyl patches under review

The FDA has ordered Janssen, the manufacturer of Duragesic — marketed as Durogesic in Australia — and manufacturers of generic fentanyl patches to change the writing on their patches to make them more visible.

Fentanyl patches are PBS listed for chronic severe disabling pain not responding to non-narcotic analgesics.

Two Australian cases of suspected accidental exposure of Durogesic in children have been reported to the TGA, one in 2009 which resulted in somnolence and another, in 2010, in which a boy lost consciousness.

Latest

Trending